Direct to Implant Breast Reconstruction Based Pre- or Retropectoral

NCT ID: NCT03143335

Last Updated: 2019-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-01

Study Completion Date

2020-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine different outcomes of breast reconstruction in women who are treated for breast cancer with skin sparing mastectomy and subsequently a primary implant based reconstruction by one of two different techniques with either a pre- or retropectoral placement of the implant.

The main objective of the study is to establish whether one of these techniques may result in a superior outcome and thus should be recommended as first choice treatment rather than the other.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women diagnosed with breast cancer, large areas of ductal carcinoma in situ or a hereditary high risk of breast cancer are offered a mastectomy either as a therapeutic or a risk reducing intervention. Those, who are found eligible for an immediate breast reconstruction using an implant are reconstructed by either a skin sparing mastectomy (SSM) or a nipple sparing mastectomy (NSM) using an extracellular matrix. The current technique is to place the implant in a retropectoral pocket in which the cranial part of the implant is covered by the major pectoral muscle, whereas the caudal part of the implant is covered and supported by an extracellular dermal matrix (ADM) as a hammock.

Recent focus on the functional outcome has, however, identified a new challenge - breast animation deformity (BAD), breast distortion or "jumping breast". The consequence of the condition is that women with aesthetic pleasant results, in rest, experience breast animation deformity during contraction of the major pectoral muscle. Evaluation of forty breast augmented women with a subpectoral positioning of the implant revealed that 77.5% had some kind of distortion during movement of the arm. In these healthy individuals, however, the condition is partly hidden by the glandular tissue and subcutaneous fatty tissue.

The condition is more severe in women with a reconstructed breast using a retropectorally placed implant, where the glandular tissue has been removed, leaving only the subcutaneous fatty tissue to cover the muscle and implant. The investigators know from experience and from reviewing unpublished clinical pictures and videos of thirty patients, who had an immediate breast reconstruction using the hammock technique, that the vast majority of patients have a pronounced degree of BAD.

Patients, who have a prepectoral placement of their implant, tend to have a lesser degree of BAD. The functional outcome of the prepectoral placement of the implant has previously not been compared to the retropectoral placement of the implant in women reconstructed by an implant and an ADM. A possible disadvantage of a prepectoral placement of the implant may be less soft-tissue coverage supplied by the pectoral muscle leading to higher risk of significant capsular formation. Less soft-tissue coverage may also result in a more visible implant border and rippling. Furthermore, the implant will not benefit from the abundant vascularity of the muscle and in theory perhaps not be as resistant to infections and implant loss as the subpectoral positioned implants.

The primary aim of this study is to compare the degree of BAD following a prepectoral to a retropectoral placement of the implant using the hammock for immediate breast reconstruction. For this purpose we have designed two separate trials:

Retrospective Follow-up trial: The investigators plan to invite a total of forty patients to compare breast animation deformity and shoulder and arm morbidity in a retrospective cohort of patients. Twenty patients, who have had a conventional immediate breast reconstruction with a retropectoral placement of the implant will be compared to twenty patients , who have had an immediate breast reconstruction with a prepectoral placement of the implant.

Randomized clinical trial: Investigators plan to collect, examine and compare data on the two surgical techniques in order to test superiority of the prepectoral implant based reconstruction in accordance with our hypothesis that it leads to lesser degree of BAD and better functional outcomes.

The trial is thus designed with two parallel study-arms as participants are allocated to reconstruction by either retro- or prepectoral placement of the implant in the ratio 1:1.

As the clinically most important parameter seems to be breast animation deformity this will serve as primary end-point. Functional changes in shoulder and arm function between the two surgical techniques is also a very important perimeter to investigate and will be analysed as secondary end-points.

In addition to the above data a number of other patient related outcomes will be collected as part of this trial.

Designed as a multicentre trial, participant enrollment and data Collection will be performed at academic Hospitals in Denmark and Norway.

A password protected Electronic database placed on a secure server will be established. This database will only be accessible to the primary investigator of the research Group who will be involved in the analysis of the data.

This study will provide a better knowledge of the expected outcome of immediate breast reconstruction, when it is performed by one of these two surgical techniques. The investigators expect that these results will help determine if the prepectoral implant placement may represent a better and gentler method for reconstruction of the breast with lower morbidity than the retropectoral implant placement. In all cases the results of this trial will enable us to provide our patients with better and more objective information, before they are subjected to immediate breast reconstruction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Reconstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Retropectoral immediate breast reconstruction

Participants are randomized to immediate breast reconstruction with the implant placed retropectoral.

Group Type ACTIVE_COMPARATOR

Retropectoral immediate breast reconstruction

Intervention Type PROCEDURE

Immediate reconstruction with the implant placed in a standard fashion, i.e. retropectoral in combination with an acellular dermal matrix.

Prepectoral immediate breast reconstruction

Participants are randomized to direct to immediate breast reconstruction with the implant placed prepectoral using acellular dermal matrix for support.

Group Type ACTIVE_COMPARATOR

Prepectoral immediate breast reconstruction

Intervention Type PROCEDURE

Immediate breast reconstruction with the implant placed prepectoral supported by acellular dermal matrix alone.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Retropectoral immediate breast reconstruction

Immediate reconstruction with the implant placed in a standard fashion, i.e. retropectoral in combination with an acellular dermal matrix.

Intervention Type PROCEDURE

Prepectoral immediate breast reconstruction

Immediate breast reconstruction with the implant placed prepectoral supported by acellular dermal matrix alone.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Women over 18 years referred to the Department of plastic surgery, Odense University Hospital, Lillebaelt Hospital Vejle, Denmark or Telemark Hospital, Skien, Norway between January 2017 and July 2018, who are found eligible for immediate breast reconstruction.

Exclusion Criteria

1. Dementia that makes it impossible to obtain informed consent
2. Non-Danish speaking patients from whom informed consent cannot be obtained by interpreter
3. Tobacco users
4. Women with known hypertension treated with more than one drug
5. Women who had pre-surgical radiation therapy.
6. Women planned to have postsurgical radiation therapy.
7. BMI above 32 or below 22

However, the final decision relies on sufficient thickness of the skin flaps after mastectomy prior to immediate reconstruction.

Invited patient will receive both oral and written participant information after which there will be as many days for reflection as the treatment guaranty for cancer allows.

Patients considering participation will be invited for a second consultation where written informed consent will be obtained from all who accept the invitation. Randomization will be performed during surgery, prior to reconstruction. Patients who do not wish to participate will be reconstruction with the implant placed retropectoral.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sygehus Lillebaelt

OTHER

Sponsor Role collaborator

Sykehuset Telemark

OTHER_GOV

Sponsor Role collaborator

Odense University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Diana Lydia Dyrberg

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jørn Bo JB Thomsen, MD, PhD

Role: STUDY_CHAIR

Center Hospital Vejle, Institute of Regional Health Research, University of Southern Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Odense University Hospital

Odense, , Denmark

Site Status

Lillebaelt Hospital Vejle

Vejle, , Denmark

Site Status

Telemark Hospital

Skien, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark Norway

References

Explore related publications, articles, or registry entries linked to this study.

Dyrberg DL, Gunnarsson GL, Bille C, Sorensen JA, Thomsen JB. Direct-to-Implant Extracellular Matrix Hammock-based Breast Reconstruction; Prepectoral or Subpectoral? Trials. 2020 Feb 10;21(1):160. doi: 10.1186/s13063-020-4125-6.

Reference Type DERIVED
PMID: 32041661 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S-2016060

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lymphovenous Anastomosis for Breast Cancer Lymphedema
NCT06302361 ACTIVE_NOT_RECRUITING NA